JP2007535519A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007535519A5 JP2007535519A5 JP2007509994A JP2007509994A JP2007535519A5 JP 2007535519 A5 JP2007535519 A5 JP 2007535519A5 JP 2007509994 A JP2007509994 A JP 2007509994A JP 2007509994 A JP2007509994 A JP 2007509994A JP 2007535519 A5 JP2007535519 A5 JP 2007535519A5
- Authority
- JP
- Japan
- Prior art keywords
- package
- days
- period
- dosing cycle
- additional dosing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 claims 11
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 claims 11
- 229960002568 ethinylestradiol Drugs 0.000 claims 11
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 10
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 claims 10
- 229960004845 drospirenone Drugs 0.000 claims 10
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 claims 10
- 239000000583 progesterone congener Substances 0.000 claims 10
- 230000000740 bleeding effect Effects 0.000 claims 9
- 229940011871 estrogen Drugs 0.000 claims 9
- 239000000262 estrogen Substances 0.000 claims 9
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 claims 5
- 229960003309 dienogest Drugs 0.000 claims 5
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 claims 3
- -1 guestden Chemical compound 0.000 claims 3
- 229960004400 levonorgestrel Drugs 0.000 claims 3
- 229930182833 estradiol Natural products 0.000 claims 2
- 229960005309 estradiol Drugs 0.000 claims 2
- 229940068196 placebo Drugs 0.000 claims 2
- 239000000902 placebo Substances 0.000 claims 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 208000005171 Dysmenorrhea Diseases 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- IMONTRJLAWHYGT-ZCPXKWAGSA-N Norethindrone Acetate Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@](C#C)(OC(=O)C)[C@@]1(C)CC2 IMONTRJLAWHYGT-ZCPXKWAGSA-N 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 239000003433 contraceptive agent Substances 0.000 claims 1
- 230000002254 contraceptive effect Effects 0.000 claims 1
- 229960000978 cyproterone acetate Drugs 0.000 claims 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 claims 1
- 229960004976 desogestrel Drugs 0.000 claims 1
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 claims 1
- GCKFUYQCUCGESZ-BPIQYHPVSA-N etonogestrel Chemical compound O=C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 GCKFUYQCUCGESZ-BPIQYHPVSA-N 0.000 claims 1
- 229940124566 female contraceptive agent Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229960001652 norethindrone acetate Drugs 0.000 claims 1
- 229960000417 norgestimate Drugs 0.000 claims 1
- KIQQMECNKUGGKA-NMYWJIRASA-N norgestimate Chemical compound O/N=C/1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(OC(C)=O)C#C)[C@@H]4[C@@H]3CCC2=C\1 KIQQMECNKUGGKA-NMYWJIRASA-N 0.000 claims 1
- 201000010065 polycystic ovary syndrome Diseases 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- JUNDJWOLDSCTFK-MTZCLOFQSA-N trimegestone Chemical compound C1CC2=CC(=O)CCC2=C2[C@@H]1[C@@H]1CC[C@@](C(=O)[C@@H](O)C)(C)[C@@]1(C)CC2 JUNDJWOLDSCTFK-MTZCLOFQSA-N 0.000 claims 1
- 229950008546 trimegestone Drugs 0.000 claims 1
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56644304P | 2004-04-30 | 2004-04-30 | |
| US57502404P | 2004-05-28 | 2004-05-28 | |
| US57719904P | 2004-06-07 | 2004-06-07 | |
| US63838004P | 2004-12-27 | 2004-12-27 | |
| US66006805P | 2005-03-10 | 2005-03-10 | |
| PCT/EP2005/004777 WO2005105103A2 (en) | 2004-04-30 | 2005-04-29 | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012227416A Division JP6134491B2 (ja) | 2004-04-30 | 2012-10-12 | 延長されたホルモン避妊法における破綻出血の管理 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007535519A JP2007535519A (ja) | 2007-12-06 |
| JP2007535519A5 true JP2007535519A5 (enExample) | 2008-08-07 |
Family
ID=35056905
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007509994A Withdrawn JP2007535519A (ja) | 2004-04-30 | 2005-04-29 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2012227416A Expired - Lifetime JP6134491B2 (ja) | 2004-04-30 | 2012-10-12 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2015126043A Expired - Lifetime JP6153967B2 (ja) | 2004-04-30 | 2015-06-23 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2016241318A Withdrawn JP2017048253A (ja) | 2004-04-30 | 2016-12-13 | 延長されたホルモン避妊法における破綻出血の管理 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012227416A Expired - Lifetime JP6134491B2 (ja) | 2004-04-30 | 2012-10-12 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2015126043A Expired - Lifetime JP6153967B2 (ja) | 2004-04-30 | 2015-06-23 | 延長されたホルモン避妊法における破綻出血の管理 |
| JP2016241318A Withdrawn JP2017048253A (ja) | 2004-04-30 | 2016-12-13 | 延長されたホルモン避妊法における破綻出血の管理 |
Country Status (29)
| Country | Link |
|---|---|
| US (3) | US8163721B2 (enExample) |
| EP (1) | EP1747001B1 (enExample) |
| JP (4) | JP2007535519A (enExample) |
| KR (4) | KR101812160B1 (enExample) |
| CN (1) | CN103127156A (enExample) |
| AR (1) | AR048722A1 (enExample) |
| AU (1) | AU2005237255B2 (enExample) |
| BR (1) | BRPI0510493A (enExample) |
| CA (1) | CA2562296A1 (enExample) |
| CR (1) | CR8709A (enExample) |
| DK (1) | DK1747001T3 (enExample) |
| EA (2) | EA031227B1 (enExample) |
| EC (1) | ECSP066999A (enExample) |
| ES (1) | ES2704999T3 (enExample) |
| HU (1) | HUE041475T2 (enExample) |
| IL (1) | IL178458A (enExample) |
| LT (1) | LT1747001T (enExample) |
| MX (1) | MXPA06012567A (enExample) |
| MY (1) | MY151322A (enExample) |
| NO (1) | NO341685B1 (enExample) |
| NZ (1) | NZ586107A (enExample) |
| PA (1) | PA8631801A1 (enExample) |
| PE (1) | PE20060467A1 (enExample) |
| SG (2) | SG152288A1 (enExample) |
| SI (1) | SI1747001T1 (enExample) |
| SV (1) | SV2006002100A (enExample) |
| TW (1) | TWI374735B (enExample) |
| UY (1) | UY28875A1 (enExample) |
| WO (1) | WO2005105103A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020132801A1 (en) * | 2001-01-11 | 2002-09-19 | Schering Aktiengesellschaft | Drospirenone for hormone replacement therapy |
| MY151322A (en) * | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
| US20070088010A1 (en) * | 2005-10-17 | 2007-04-19 | Doris Huebler | Method of making a single-stage pharmaceutical preparation for oral therapy of dysfunctional uterine bleeding, containing ethinyl estradiol and dienogest |
| EP1977752A1 (de) * | 2007-03-01 | 2008-10-08 | Bayer Schering Pharma Aktiengesellschaft | Pharmazeutische Zubereitung zur Verminderung der Endometriose |
| DE102007011105A1 (de) * | 2007-03-02 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | Mineralcorticoid-Rezeptor-Antagonisten zur Behandlung von Endometriose |
| KR20110045065A (ko) * | 2008-09-16 | 2011-05-03 | 플레이텍스 프로덕츠, 엘엘씨. | 월경 억제, 피임 및 호르몬 대체 요법을 위한 약제 및 이를 투여하는 방법 |
| CA2740004A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc. | Transdermal delivery |
| ES2734510T3 (es) | 2008-10-08 | 2019-12-10 | Agile Therapeutics Inc | Administración transdérmica |
| US9198919B2 (en) | 2008-10-08 | 2015-12-01 | Agile Therapeutics, Inc. | Contraceptive transdermal delivery of hormones |
| WO2010111488A1 (en) | 2009-03-27 | 2010-09-30 | Agile Therapeutics, Inc. | Transdermal delivery |
| AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
| US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
| US9603860B2 (en) | 2010-07-28 | 2017-03-28 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
| EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
| HUE054551T2 (hu) | 2015-06-18 | 2021-09-28 | Estetra Sprl | Ösztetrolt tartalmazó, szájban diszpergálódó tabletta |
| NZ737948A (en) | 2015-06-18 | 2023-03-31 | Estetra Sprl | Orodispersible dosage unit containing an estetrol component |
| LT3310345T (lt) | 2015-06-18 | 2021-06-25 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
| KR102662025B1 (ko) | 2015-06-18 | 2024-05-02 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 에스테트롤 성분을 함유하는 구강분해성 투여 단위 |
| LT3313408T (lt) * | 2015-06-23 | 2024-03-12 | Laboratorios Leon Farma Sa | Kontraceptikas drospirenono pagrindu, skirtas pacientėms, turinčioms antsvorio |
| CA3178291A1 (en) | 2016-08-05 | 2018-04-12 | Estetra Srl | Method for the management of dysmenorrhea and menstrual pain |
| BR112019006227A2 (pt) | 2016-09-30 | 2019-06-18 | Myovant Sciences Gmbh | métodos de tratamento de leiomioma uterino e endometriose |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| US12138270B2 (en) | 2021-09-07 | 2024-11-12 | Millicent Pharma Limited | Contraceptive regimen including reduced level of estrogen |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5244096A (en) | 1988-04-22 | 1993-09-14 | Stoner Fred L | Preventive treatment kit against sexually transmitted disease |
| WO1993013801A1 (en) | 1992-01-17 | 1993-07-22 | The Procter & Gamble Company | Treatment for atherosclerosis |
| DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| US5552394A (en) | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
| US6451778B1 (en) * | 1996-07-26 | 2002-09-17 | Wyeth | Oral contraceptive |
| NZ333750A (en) * | 1996-07-26 | 2000-09-29 | American Home Prod | Monophasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| US5842441A (en) | 1996-08-26 | 1998-12-01 | Pharmalett Denmark A/S | Medicated and individualized treatment shampoo for dermatological disturbances of companion animals |
| US5898032A (en) * | 1997-06-23 | 1999-04-27 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy |
| DE19739916C2 (de) * | 1997-09-11 | 2001-09-13 | Hesch Rolf Dieter | Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen |
| RS50262B2 (sr) * | 1999-08-31 | 2018-10-31 | Bayer Pharma AG | Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva |
| US6787531B1 (en) * | 1999-08-31 | 2004-09-07 | Schering Ag | Pharmaceutical composition for use as a contraceptive |
| CO5271709A1 (es) | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | Composiciones y procedimientos para el y tratamiento de afecciones que responden a estrogenos |
| US6653298B2 (en) * | 2000-01-14 | 2003-11-25 | Sterix Limited | Composition |
| DE10045380A1 (de) * | 2000-09-14 | 2002-04-04 | Schering Ag | Verfahren zur Kontrazeption und dessen Darreichungsform |
| IL145876A0 (en) | 2000-10-17 | 2002-07-25 | Pfizer Prod Inc | Methods and kits for improving vascular health |
| US20020193356A1 (en) * | 2001-05-23 | 2002-12-19 | Van Beek Agatha Antonia Magdalena | Means and method for hormonal contraception |
| US20030018018A1 (en) | 2001-07-10 | 2003-01-23 | Medical College Of Hampton Roads | Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea |
| MY151322A (en) * | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
| US8501720B2 (en) | 2004-07-30 | 2013-08-06 | Bayer Pharma AG | Method for treatment of dysmenorrhea |
-
2005
- 2005-04-19 MY MYPI20051728 patent/MY151322A/en unknown
- 2005-04-27 UY UY28875A patent/UY28875A1/es not_active IP Right Cessation
- 2005-04-29 SI SI200532240T patent/SI1747001T1/sl unknown
- 2005-04-29 SG SG200902990-1A patent/SG152288A1/en unknown
- 2005-04-29 ES ES05740127T patent/ES2704999T3/es not_active Expired - Lifetime
- 2005-04-29 DK DK05740127.5T patent/DK1747001T3/en active
- 2005-04-29 HU HUE05740127A patent/HUE041475T2/hu unknown
- 2005-04-29 BR BRPI0510493-9A patent/BRPI0510493A/pt not_active Application Discontinuation
- 2005-04-29 EA EA201200377A patent/EA031227B1/ru not_active IP Right Cessation
- 2005-04-29 MX MXPA06012567A patent/MXPA06012567A/es active IP Right Grant
- 2005-04-29 WO PCT/EP2005/004777 patent/WO2005105103A2/en not_active Ceased
- 2005-04-29 AU AU2005237255A patent/AU2005237255B2/en not_active Expired
- 2005-04-29 KR KR1020157012286A patent/KR101812160B1/ko not_active Expired - Lifetime
- 2005-04-29 EP EP05740127.5A patent/EP1747001B1/en not_active Revoked
- 2005-04-29 KR KR1020067022523A patent/KR20070004919A/ko not_active Ceased
- 2005-04-29 KR KR1020167035558A patent/KR20160150113A/ko not_active Ceased
- 2005-04-29 SV SV2005002100A patent/SV2006002100A/es unknown
- 2005-04-29 LT LTEP05740127.5T patent/LT1747001T/lt unknown
- 2005-04-29 NZ NZ586107A patent/NZ586107A/en not_active IP Right Cessation
- 2005-04-29 CA CA002562296A patent/CA2562296A1/en not_active Abandoned
- 2005-04-29 TW TW094113795A patent/TWI374735B/zh not_active IP Right Cessation
- 2005-04-29 EA EA200601908A patent/EA016625B1/ru not_active IP Right Cessation
- 2005-04-29 SG SG10201701904TA patent/SG10201701904TA/en unknown
- 2005-04-29 JP JP2007509994A patent/JP2007535519A/ja not_active Withdrawn
- 2005-04-29 CN CN2012105794658A patent/CN103127156A/zh active Pending
- 2005-04-29 KR KR1020137001481A patent/KR20130022425A/ko not_active Ceased
- 2005-05-02 US US11/118,779 patent/US8163721B2/en not_active Expired - Fee Related
- 2005-05-02 AR ARP050101738A patent/AR048722A1/es not_active Application Discontinuation
- 2005-05-03 PA PA20058631801A patent/PA8631801A1/es unknown
- 2005-05-03 PE PE2005000490A patent/PE20060467A1/es not_active Application Discontinuation
-
2006
- 2006-10-05 IL IL178458A patent/IL178458A/en active IP Right Grant
- 2006-10-25 CR CR8709A patent/CR8709A/es not_active Application Discontinuation
- 2006-11-13 EC EC2006006999A patent/ECSP066999A/es unknown
- 2006-11-28 NO NO20065499A patent/NO341685B1/no unknown
-
2012
- 2012-04-17 US US13/448,585 patent/US20120202779A1/en not_active Abandoned
- 2012-10-12 JP JP2012227416A patent/JP6134491B2/ja not_active Expired - Lifetime
-
2015
- 2015-03-09 US US14/642,096 patent/US20150174142A1/en not_active Abandoned
- 2015-06-23 JP JP2015126043A patent/JP6153967B2/ja not_active Expired - Lifetime
-
2016
- 2016-12-13 JP JP2016241318A patent/JP2017048253A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007535519A5 (enExample) | ||
| RU2009120528A (ru) | Способы гормональной терапии возрастающими дозами в режиме пролонгированного цикла | |
| CA2640520C (en) | Extended cycle multiphasic oral contraceptive method | |
| JP2010508275A5 (enExample) | ||
| FI98985C (fi) | Ehkäisyvalmiste | |
| AU725670B2 (en) | Progestogen-anti-progestogen regimens | |
| CN100560132C (zh) | 避孕方法及用于其的给药形式 | |
| KR101812160B1 (ko) | 연장된 호르몬성 피임제 투약법에서 파탄성 출혈의 관리 | |
| JP2019163318A5 (enExample) | ||
| US20050113350A1 (en) | Extended use combination comprising estrogens and progestins | |
| JP2004508398A5 (enExample) | ||
| JPH04290828A (ja) | 低エストロゲン経口避妊薬 | |
| IL187471A (en) | Quadraphasic continuous graduated estrogen contraceptive | |
| JP2007512291A (ja) | 2種のエストロゲン及び/又はプロゲスチン組成物を含んで成る、21〜28日よりも長い期間にわたっての連続ホルモン処理のための医薬製剤 | |
| RU2004113305A (ru) | Комбинированный эстрогенный/гестагенный препарат и его применение | |
| JP2008540482A5 (enExample) | ||
| HK1205468A1 (en) | Extended estrogen dosing contraceptive regimen | |
| JP2007511533A (ja) | 段階的エストロゲン避妊薬 | |
| JP2010539153A5 (enExample) | ||
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| JP2008515909A5 (enExample) | ||
| HUP9904345A2 (hu) | Orális fogamzásgátló | |
| US7297688B2 (en) | Starter kit for low dose oral contraceptives | |
| CA2556459C (en) | Extended cycle multiphasic oral contraceptive method | |
| CA2623024A1 (en) | Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives |